Press Release IFRC-DREF calls on global donors to help the world ‘Stand Tall’ in the face of accelerating humanitarian need – supporting smarter and faster disaster relief 3 December 2023
Press Release St. Jude Memphis Marathon Weekend Raises $15 Million for Childhood Cancer, Estimated $43 Million Boost to Memphis Businesses 2 December 2023
Press Release SMR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that NuScale Power Corporation Investors with Substantial Losses Have Opportunity to Lead Case 2 December 2023
Press Release SLRN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit 2 December 2023
Press Release MDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Veradigm Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case 2 December 2023
Press Release CHPT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ChargePoint Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit 2 December 2023
Press Release EXFY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Expensify, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit 2 December 2023
Press Release PAYC INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Paycom Software, Inc. Investors with Substantial Losses Have Opportunity to Lead Case 2 December 2023
Press Release DLOCAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DLocal Ltd and Encourages Investors to Contact the Firm 2 December 2023
Press Release EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Eagle Pharmaceuticals, Inc. on Behalf of Eagle Pharmaceuticals Stockholders and Encourages Investors to Contact the Firm 2 December 2023
